Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
ConditionGastroenteritis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorCentral Hospital, Nancy, France
About this trial
Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture)
(ii) Determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection)
(iii) Explore factors that could impact fecal phage carriage (patients with digestive symptoms vs. healthy individuals, immunocompromised patients vs. immunocompetent patients)
Eligibility criteria
Qualifiers
Age between 18 and 60.
Persons having developed gastrointestinal symptoms justifying microbiological stool testing at the time of hospitalization.
Person having received full information on the organization of the research and not having objected to the use of this data
Disqualifiers
Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the French Public Health Code.
Pregnant or breast-feeding women,
Minors (not emancipated),
Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice),
Trial design
Treatments tested in this trial
- bacteriophage detection
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov